Amylyx Pharmaceuticals Inc (AMLX)
1.84
+0.01
(+0.55%)
USD |
NASDAQ |
May 17, 16:00
1.84
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Free Cash Flow: 15.44M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.44M |
| December 31, 2023 | 10.68M |
| September 30, 2023 | -52.83M |
| June 30, 2023 | -90.84M |
| March 31, 2023 | -146.74M |
| Date | Value |
|---|---|
| December 31, 2022 | -182.40M |
| September 30, 2022 | -160.51M |
| June 30, 2022 | -137.99M |
| March 31, 2022 | -103.47M |
| December 31, 2021 | -75.15M |
Free Cash Flow Range, Past 5 Years
-182.40M
Minimum
Dec 2022
15.44M
Maximum
Mar 2024
-92.38M
Average
-97.16M
Median
Free Cash Flow Benchmarks
| Cassava Sciences Inc | -87.90M |
| iRhythm Technologies Inc | -113.15M |
| Bristol-Myers Squibb Co | 12.51B |
| Moderna Inc | -3.672B |
| ACADIA Pharmaceuticals Inc | 63.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.489M |
| Cash from Investing (Quarterly) | 0.819M |
| Cash from Financing (Quarterly) | 0.131M |
| Free Cash Flow Per Share (Quarterly) | -0.0082 |
| Free Cash Flow to Equity (Quarterly) | -0.556M |
| Free Cash Flow to Firm (Quarterly) | -0.556M |
| Free Cash Flow Yield | 12.11% |